Stock Fundamentals

Company Information

Company Name
Immunitybio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45256X1037
CIK: 0001326110
CUSIP: 45256X103
Currency: USD
Full Time Employees: 684
Phone: 844 696 5235
Fiscal Year End: December
IPO Date: Jul 28, 2015
Description:

ImmunityBio, Inc., a biotechnology company, focuses on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient's immune system and deliver durable protection against cancer and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors; and 3M-052, a synthetic TLR7/8 agonist and 3M-052 formulations and related technology. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeOne Medicines Ltd. It has license agreement with 3M Innovative Properties Company and Access to Advanced Health Institute. ImmunityBio, Inc. is based in San Diego, California.

Address:

3530 John Hopkins Court, San Diego, CA, United States, 92121

Directors & Officers

Name Title Year Born
Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., M.S., M.Sc. Founder, Executive Chairman and Global Chief Scientific & Medical Officer 1953
Mr. Richard Gerald Adcock President, CEO & Director 1969
Mr. David C. Sachs Chief Financial Officer 1978
Ms. Regan J. Lauer Chief Accounting Officer 1970
Dr. Barry J. Simon M.D. Chief Corporate Affairs Officer & Director 1965
Dr. Enrique Diloné Ph.D., RAC Chief Technology Officer 1967
Ms. Sarah Singleton Chief Communications Officer & Head of Patient Advocacy NA
Ms. Emily Arison Senior Vice President of Human Resources NA
Dr. Leonard S. Sender M.D. Chief Medical Officer of Liquid Tumors & Cell Therapy NA
Dr. Sandeep K. Reddy M.D. Chief Medical Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 24, 2026 Barry J Simon N/A Sale 75.00K $12.01 $900.75K
Feb 23, 2026 Barry J Simon N/A Sale 165.00K $10.25 $1.69M
Feb 23, 2026 Christobel Selecky N/A Sale 25.00K $10.00 $250.00K
Feb 20, 2026 Barry J Simon N/A Sale 10.00K $9.25 $92.50K
Jan 20, 2026 Barry J Simon N/A Sale 151.97K $7.20 $1.09M
Jan 20, 2026 Christobel Selecky N/A Sale 25.00K $7.51 $187.75K
Jan 16, 2026 Christobel Selecky N/A Sale 50.00K $5.00 $250.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 32.78M Dec 31, 2025 3.13% $0.00 18.52%
BlackRock Inc 26.35M Mar 31, 2026 2.52% $0.00 2.91%
State Street Corp 17.71M Mar 31, 2026 1.69% $0.00 7.61%
Vanguard Portfolio Management, LLC 16.32M Mar 31, 2026 1.56% $0.01 0.00%
Vanguard Capital Management, LLC 15.13M Mar 31, 2026 1.44% $0.00 0.00%
D. E. Shaw & Co LP 12.57M Mar 31, 2026 1.20% $0.06 0.00%
Geode Capital Management, LLC 8.03M Mar 31, 2026 0.77% $0.00 1.41%
Two Sigma Investments LLC 4.39M Mar 31, 2026 0.42% $0.03 -7.04%
Morgan Stanley - Brokerage Accounts 4.02M Mar 31, 2026 0.38% $0.00 -21.29%
HRT FINANCIAL LLC 3.93M Mar 31, 2026 0.37% $0.08 0.00%
Woodline Partners LP 3.45M Mar 31, 2026 0.33% $0.10 0.02%
The Goldman Sachs Group Inc 3.24M Mar 31, 2026 0.31% $0.00 -47.39%
UBS Group AG 2.94M Mar 31, 2026 0.28% $0.00 47.57%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 2.93M Mar 31, 2026 0.28% $0.09 0.00%
Northern Trust Corp 2.50M Mar 31, 2026 0.24% $0.00 12.32%
Charles Schwab Investment Management Inc 2.48M Mar 31, 2026 0.24% $0.00 -0.95%
Bank of America Corp 2.45M Mar 31, 2026 0.23% $0.00 2.74%
SEB Asset Management AB 2.45M Mar 31, 2026 0.23% $0.08 0.00%
Vanguard Fiduciary Trust Co 2.12M Mar 31, 2026 0.20% $0.00 0.00%
Barclays PLC 1.89M Mar 31, 2026 0.18% $0.00 -22.67%

Shares Statistics

Shares Outstanding: 1.05B
Shares Float: 394.06M
% Insiders: 6,247.60%
% Institutions: 1,757.20%
Short % Float: 34.02%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 11.48M 1.10% ▲ 1.16% Apr 30, 2026
2 State Street® SPDR® S&P® Biotech ETF 11.34M 1.08% ▼ 0.61% May 31, 2026
3 Vanguard Small Cap Index 8.29M 0.79% ▼ 0.08% Apr 30, 2026
4 iShares Russell 2000 ETF 7.03M 0.67% ▲ 0.93% May 29, 2026
5 Vanguard Small Cap Growth Index Inv 4.67M 0.45% ▲ 0.54% Apr 30, 2026
6 Vanguard Institutional Extnd Mkt Idx Tr 3.45M 0.33% ▲ 1.08% Apr 30, 2026
7 Fidelity Small Cap Index 2.89M 0.28% ▲ 0.17% Mar 31, 2026
8 iShares Biotechnology ETF 2.54M 0.24% ▲ 1.44% May 29, 2026
9 SEB Läkemedelsfond 2.45M 0.23% ▲ 0.00% May 31, 2026
10 iShares Russell 2000 Growth ETF 1.99M 0.19% ▼ 0.65% May 29, 2026

Valuation Metrics

Enterprise Value: $7.77B
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $7.44B
EBITDA: $-245.41M
Book Value: $-0.83
Earnings/Share: $-0.85
Profit Margin: 0.00%
Operating Margin: -157.88%
ROA (TTM): -34.38%
ROE (TTM): 0.00%
Revenue (TTM): $140.98M
Revenue/Share (TTM): $0.15
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 167.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 5.10x -0.97x 2.00x -2.28x -2.18x
2024-12-31 3.36x -0.96x 2.27x -2.61x -1.77x
2023-12-31 5.05x -1.17x 2.16x -4.18x -1.43x
2022-12-31 0.28x -1.51x 2.24x -7.45x -1.92x
2021-12-31 0.91x -2.51x 1.52x -22.24x -1.90x
2020-12-31 1.64x -2.16x 1.54x -24.34x -1.27x
2019-12-31 4.82x 0.03x 0.16x -11.30x -0.07x
2018-12-31 3.26x 0.01x 0.20x -227.23x -0.01x
2017-12-31 6.35x 0.00x 0.13x -160.39x 0.00x
2016-12-31 16.34x 0.00x 0.08x -1,886.36x 0.00x
2015-12-31 48.40x 0.00x 0.03x N/A 0.00x
2014-12-31 24.69x 0.00x 0.04x N/A -0.05x
2013-12-31 0.20x -0.61x 2.38x -4.90x -1.11x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IBRX.US!